XML 39 R25.htm IDEA: XBRL DOCUMENT v3.24.4
Significant Accounting Policies (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Significant Accounting Policies [Abstract]    
Schedule of Basic and Diluted Loss per Share The following table sets forth the computation of basic and diluted loss per share (in thousands, except per share data):
   

Three Months Ended

September 30,

   

Nine Months Ended

September 30,

 
    2024     2023     2024     2023  
Numerator:                        
Net loss   $ (5,675 )   $ (6,841 )   $ (17,305 )   $ (20,395 )
Less: Series A convertible preferred stock dividends     -       (215 )     -       (646 )
Net loss attributable to common stockholders – basic and diluted   $ (5,675 )   $ (7,056 )   $ (17,305 )   $ (21,041 )
Denominator:                                
Weighted average shares used in computing net loss per common share – basic and diluted     93,048       71,588       89,063       64,246  
Net loss per common share – basic and diluted   $ (0.06 )   $ (0.10 )   $ (0.19 )   $ (0.33 )
The following table sets forth the computation of basic and diluted loss per share (in thousands, except per share data):
   Year Ended December 31, 
   2023   2022 
Numerator:        
Net loss  $(27,022)  $(25,978)
Less: Series A convertible preferred stock dividends   861    889 
Net loss available to common stockholders – basic and diluted  $(27,883)  $(26,867)
Denominator:          
Weighted average shares used in computing net loss per common share – basic and diluted   66,611    36,680 
Loss per share - basic and diluted  $(0.42)  $(0.73)
Schedule of Securities Outstanding The following is a summary of the weighted average common stock equivalents for the securities outstanding during the respective periods that have been excluded from the computation of diluted net loss per common share, as their effect would be anti-dilutive (in thousands):
  

Three Months Ended

September 30,

  

Nine Months Ended

September 30,

 
   2024   2023   2024   2023 
Warrants   2,212    5,973    2,538    6,092 
Options   12,407    13,069    12,882    11,410 
Unvested restricted common stock   2,997    1,783    2,997    771 
Total potentially dilutive shares   17,616    20,825    18,417    18,273 
The following is a summary of the weighted average common stock equivalents for the securities outstanding during the respective periods that have been excluded from the computation of diluted net loss per common share, as their effect would be anti-dilutive (in thousands):
   Year Ended December 31, 
   2023   2022 
Warrants   6,053    3,976 
Options   12,280    6,830 
Unvested restricted common stock   1,192    
-
 
Total potentially dilutive shares   19,525    10,778